Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...

We invite teenagers to tell a true story about a meaningful life experience in just 100 words. Contest dates: Nov. 6 to Dec. 4, 2024. By The Learning Network We invite teenagers to post their ...

Anticoagulants and antiplatelet agents pose a great risk in patients undergoing surgery. Because these products inhibit at least one, and often multiple, factors in the clotting cascade, patients ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the ...

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...